Search Results

• • 24 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Interferon-[alpha] plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: A pilot study.

  Authors:Robert J. Amato and Anish RawatFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006290 words Report, Brief articl...

   Abstract Only

• Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial.

  Authors:Sanjay Singh Negi, Anil Agarwal, and Adarsh ChaudharyFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006270 words Clinical report, Bri...

   Abstract Only

• Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study.

  Authors:Emilio Esteban, Joaquin Fra, Yolanda Fernández, Norberto Corral, José M. Vieitez, Isabel Palacio, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006337 words Clinical report, Bri...

   Abstract Only

• Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks

  Authors:Peter Johnson, Thomas Geldart, Pierre Fumoleau, Marie-Claire Pinel, Laurent Nguyen, and Ian JudsonFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1640L

   Citation Only

• Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer.

  Authors:Athanassios Argiris, Victoria Kut, Lynn Luong, and Michael J. AvramFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006408 words Report

   Abstract Only

• Phase I trial of oral talactoferrin alfa in refractory solid tumors.

  Authors:Teresa G. Hayes, Gerald F. Falchook, Gauri R. Varadhachary, Dori P. Smith, Lisa D. Davis, Hari M. Dhingra, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006348 words Report, Brief articl...

   Abstract Only

• Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer

  Authors:Athanassios Argiris, Victoria Kut, Lynn Luong, and Michael J. AvramFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1560L

   Citation Only

• Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma.

  Authors:Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Mann Kim, Yulin Zhang, Mary Jane Staab, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006343 words Report, Brief articl...

   Abstract Only

• An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma

  Authors:J.T. Hartmann, K. Oechsle, J. Huober, A. Jakob, M. Azemar, M. Horger, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1700L

   Citation Only

• Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product

  Authors:Wei Zhang, Edgar S.L. Liu, Jun Fu, Hai-Mei Tian, Ying-Jye Wu, and Shiu-Fun PangFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1520L

   Citation Only

• A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer.

  Authors:Patrapim Sunpaweravong, Lyn Magree, Rachel Rabinovitch, Paul Bunn, and Karen KellyFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006351 words Report, Brief articl...

   Abstract Only

• Flutamide in unresectable pancreatic adenocarcinoma: a randomized, double-blind, placebo-controlled trial

  Authors:Sanjay Singh Negi, Anil Agarwal, and Adarsh ChaudharyFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1580L

   Citation Only

• Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma

  Authors:Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Mann Kim, Yulin Zhang, Mary Jane Staab, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1560L

   Citation Only

• Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks.

  Authors:Peter Johnson, Thomas Geldart, Pierre Fumoleau, Marie-Claire Pinel, Laurent Nguyen, and Ian JudsonFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006217 words Report, Brief articl...

   Abstract Only

• Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures.

  Authors:José M. Padrón and Godefridus J. PetersFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006305 words Report, Brief articl...

   Abstract Only

• Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures

  Authors:Jose M. Padron and Godefridus J. PetersFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1580L

   Citation Only

• Phase I trial of oral talactoferrin alfa in refractory solid tumors

  Authors:Teresa G. Hayes, Gerald F. Falchook, Gauri R. Varadhachary, Dori P. Smith, Lisa D. Davis, Hari M. Dhingra, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1550L

   Citation Only

• Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme.

  Authors:Daniel Farray, Manmeet S. Ahluwalia, Josette Snyder, Gene H. Barnett, Bruce H. Cohen, John H. Suh, et al.From:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006229 words Clinical report, Bri...

   Abstract Only

• Interferon-[alpha] plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: a pilot study

  Authors:Robert J. Amato and Anish RawatFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006 Clinical report 1330L

   Citation Only

• Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product.

  Authors:Wei Zhang, Edgar S. L. Liu, Jun Fu, Hai-Mei Tian, Ying-Jye Wu, and Shiu-Fun PangFrom:Investigational New Drugs (Vol. 24, Issue 3) Peer-Reviewed

  May 2006255 words Report, Brief articl...

   Abstract Only